Control of Trabecular Meshwork Cytoskeleton
Control of Trabecular Meshwork Cytoskeleton
批准号:
8183518
负责人:
Donna M Peters
金额:
$37.63万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-15 至 2014-03-31
关键词:
AccountingActinsAffectAfrican AmericanAnteriorAntibodiesAqueous HumorArchitectureBlindnessCD47 geneCell Culture SystemCell Culture TechniquesCell FractionationCell physiologyCellsChemical AgentsComplexCytoskeletonDataDexamethasoneDiseaseDominant-Negative MutationElderlyEventExtracellular Matrix ProteinsEyeFamilyG-Protein-Coupled ReceptorsGlaucomaGoalsGrantGuanosine Triphosphate PhosphohydrolasesHumanIntegrin Signaling PathwayIntegrinsLeadLifeMeasuresMedicalMolecularMonkeysMovementOrgan Culture TechniquesPathway interactionsPeptidesPhysiologic Intraocular PressurePhysiologicalPlayPopulationPrimary Open Angle GlaucomaProceduresPropertyProteinsProteomicsResistanceRetinal Ganglion CellsRoleRouteSignal PathwaySignal TransductionSiteSteroidsStructure of sinus venosus of scleraSystemTestingTissuesTrabecular meshwork structureUnited StatesUp-RegulationWestern Blottinganterior chamberbasecrosslinkmemberoverexpressionpressureprotein activationreceptorresponsetherapeutic target
中文摘要
描述(申请人提供):这是EY017006的竞争性续签。这笔赠款的长期目标是确定可用作治疗靶点的细胞-基质信号机制,以控制类固醇诱导的青光眼。青光眼会导致视网膜神经节细胞不可逆转的丧失,全球约有6700万人受到影响。它们通常与由于小梁网(TM)房水流出减少而导致的眼内压(IOP)升高有关。虽然已知有许多生理因素调节流出设施,但作为流出设施重要调节机制的关键因素之一是TM的收缩特性。目前,还不清楚哪些分子事件调节TM的收缩能力。细胞外基质(ECM)蛋白及其受体(整合素)的信号特性在调节细胞收缩方面起着关键作用,我们认为这些信号通路中的一个或多个成分的激活可能是激素性青光眼形成交联型肌动蛋白网络(CLANS)的原因。我们的研究表明,地塞米松在氏族形成过程中激活了这一途径。在这一竞争性更新中,我们计划确定在存在和不存在类固醇的情况下,流出功能的变化是否与培养的前节中整合素βV?3信号的水平相关。我们还计划确定地塞米松用来激活V?3整合素的信号通路。为了帮助识别可能被类固醇上调的成分,我们计划使用定量磷酸蛋白质组学来鉴定在培养的TM细胞中整合素信号通路中不受类固醇处理调节并被整合素和CD47激活的成分。这些研究应该表明整合素信号通路(S)是否可能参与激素性青光眼。
与公共健康相关:青光眼是美国第二大致盲原因,也是非裔美国人致盲的最常见原因。由于缺乏明确的细胞培养系统,试图了解这种疾病的原因(S)一直受到阻碍。本项目的目标是确定激素性青光眼(SIG)过程中激活的信号通路(S),从而确定降低SIG的潜在治疗靶点。
英文摘要
DESCRIPTION (provided by applicant): This is a competitive renewal for EY017006. The long-term objective of this grant is to identify cell-matrix signaling mechanisms that can be used as therapeutic targets to control steroid induced glaucoma. The glaucomas, which lead to irreversible loss of retinal ganglion cells, affect approximately 67 million people worldwide. They are commonly associated with elevated levels of intraocular pressure (IOP) due to a reduction in aqueous humor outflow from the trabecular meshwork (TM). Although a number of physiological factors are known to regulate outflow facility, one of the key factors that have emerged as an important regulatory mechanism for outflow facility is the contractile properties of the TM. At the present, it is unclear what molecular events regulate contractility in the TM. It is well established that the signaling properties of extracellular matrix (ECM) proteins and their receptors (integrins) play a critical role in regulating cell contractility and we proposed that activation of one or more of the components in these signaling pathways may be responsible for the formation of cross-linked actin networks (CLANs) observed in steroid induced glaucoma. Our studies have shown that dexamethasone activates this pathway during the formation of CLANs. In this competitive renewal we plan to determine if changes in outflow facility correlate with the levels of ?v?3 integrin signaling in cultured anterior segments in the presence and absence of steroids. We also plan to identify the signaling pathways utilized by dexamethasone to activate ?v?3 integrins. To aid in the identification of components that may be upregulated by steroids we plan to use quantitative phosphoproteomics to identify components of the integrin signaling pathways that are unregulated by steroid treatment and activated by both integrin and CD47 in TM cells in culture. These studies should show whether integrin signaling pathway(s) could be involved in steroid induced glaucoma.
PUBLIC HEALTH RELEVANCE: Glaucoma is the second most common cause of blindness in the U.S. and the most common cause of blindness among African-Americans. Attempts to understand the cause(s) of this disease have been hampered by the lack of well defined cell culture systems. The goal of this project is to identify the signaling pathway(s) activated during steroid induced glaucoma (SIG) so we identify potential therapeutic targets to reduce SIG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NFAT and fibrosis in the trabecular meshwork
-
批准号:10630268
-
项目类别:
-
资助金额:$41.6万
-
财政年份:2022
-
负责人:Donna M Peters
-
依托单位:
NFAT and fibrosis in the trabecular meshwork
-
批准号:10436632
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2022
-
负责人:Donna M Peters
-
依托单位:
Targeting the Anterior Segment with Homing Peptides from Phage Display
-
批准号:8487758
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2013
-
负责人:Donna M Peters
-
依托单位:
Targeting the Anterior Segment with Homing Peptides from Phage Display
-
批准号:8651496
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2013
-
负责人:Donna M Peters
-
依托单位:
Integrin Signaling in the Trabecular Meshwork
-
批准号:8264354
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2010
-
负责人:Donna M Peters
-
依托单位:
Integrin Signaling in the Trabecular Meshwork
-
批准号:7862023
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2010
-
负责人:Donna M Peters
-
依托单位:
Integrin Signaling in the Trabecular Meshwork
-
批准号:8059627
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2010
-
负责人:Donna M Peters
-
依托单位:
Control of Trabecular Meshwork Cytoskeleton
-
批准号:7489937
-
项目类别:
-
资助金额:$34.97万
-
财政年份:2006
-
负责人:Donna M Peters
-
依托单位:
Control of Trabecular Meshwork Cytoskeleton
-
批准号:7141361
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2006
-
负责人:Donna M Peters
-
依托单位:
Control of Trabecular Meshwork Cytoskeleton
-
批准号:10316183
-
项目类别:
-
资助金额:$44.08万
-
财政年份:2006
-
负责人:Donna M Peters
-
依托单位:
Control of Trabecular Meshwork Cytoskeleton
-
批准号:8691189
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2006
-
负责人:Donna M Peters
-
依托单位:
Control of Trabecular Meshwork Cytoskeleton
-
批准号:10557068
-
项目类别:
-
资助金额:$41.37万
-
财政年份:2006
-
负责人:Donna M Peters
-
依托单位:
Control of Trabecular Meshwork Cytoskeleton
-
批准号:7908762
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2006
-
负责人:Donna M Peters
-
依托单位:
Control of Trabecular Meshwork Cytoskeleton
-
批准号:9907633
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2006
-
负责人:Donna M Peters
-
依托单位:
Control of Trabecular Meshwork Cytoskeleton
-
批准号:7661506
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2006
-
负责人:Donna M Peters
-
依托单位:
Control of Trabecular Meshwork Cytoskeleton
-
批准号:7812209
-
项目类别:
-
资助金额:$48.45万
-
财政年份:2006
-
负责人:Donna M Peters
-
依托单位:
Control of Trabecular Meshwork Cytoskeleton
-
批准号:7285580
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2006
-
负责人:Donna M Peters
-
依托单位:
CORE--PATHOLOGY/IMAGING
-
批准号:6949286
-
项目类别:
-
资助金额:$17.57万
-
财政年份:2005
-
负责人:Donna M Peters
-
依托单位:
UW Vision Research Core 2 - Pathology and Imaging
-
批准号:10273753
-
项目类别:
-
资助金额:$17.83万
-
财政年份:2005
-
负责人:Donna M Peters
-
依托单位:
Core Grant for Vision Research Core 2
-
批准号:10715683
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2005
-
负责人:Donna M Peters
-
依托单位:
海外基金